Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials

WF McIntyre, AP Benz, N Becher, JS Healey… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: Device-detected atrial fibrillation (also known as subclinical atrial fibrillation
or atrial high-rate episodes) is a common finding in patients with an implanted cardiac …

Apixaban to prevent recurrence after cryptogenic stroke in patients with atrial cardiopathy: the ARCADIA randomized clinical trial

H Kamel, WT Longstreth, DL Tirschwell, RA Kronmal… - JAMA, 2024 - jamanetwork.com
Importance Atrial cardiopathy is associated with stroke in the absence of clinically apparent
atrial fibrillation. It is unknown whether anticoagulation, which has proven benefit in atrial …

Atrial fibrillation after patent foramen Ovale closure: incidence, pathophysiology, and management

A Apostolos, D Tsiachris, M Drakopoulou… - Journal of the …, 2024 - Am Heart Assoc
This comprehensive review explores the incidence, pathophysiology, and management of
atrial fibrillation (AF) following percutaneous closure of patent foramen ovale (PFO) …

[HTML][HTML] Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA …

G Boriani, L Gerra, DA Mei, M Vitolo, M Proietti… - European Journal of …, 2024 - Elsevier
Atrial fibrillation (AF) may be asymptomatic and the extensive monitoring capabilities of
cardiac implantable electronic devices (CIEDs) revealed asymptomatic atrial tachi …

Left Atrial Strain Predicts Subclinical Atrial Fibrillation Detected by Long-term Continuous Monitoring in Elderly High-Risk Individuals

FJ Olsen, SZ Diederichsen, PG Jørgensen… - Circulation …, 2024 - Am Heart Assoc
BACKGROUND: Left atrial (LA) speckle tracking provides detailed information on atrial
function. Its utility for predicting subclinical atrial fibrillation (SCAF) is unclear. Therefore, we …

Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference

D Linz, JG Andrade, E Arbelo, G Boriani… - Europace, 2024 - academic.oup.com
Aims Recent trial data demonstrate beneficial effects of active rhythm management in
patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is …

Secondary stroke prevention in people with atrial fibrillation: treatments and trials

DJ Seiffge, V Cancelloni, L Räber, M Paciaroni… - The Lancet …, 2024 - thelancet.com
Atrial fibrillation is one of the most common cardiac arrhythmias and is a major cause of
ischaemic stroke. Recent findings indicate the importance of atrial fibrillation burden (device …

Echocardiography and electrocardiography in detecting atrial cardiomyopathy: a promising path to predicting cardioembolic strokes and atrial fibrillation

D Gentille-Lorente, A Hernández-Pinilla… - Journal of Clinical …, 2023 - mdpi.com
(1) Background: Atrial cardiomyopathy constitutes an intrinsically prothrombotic atrial
substrate that may promote atrial fibrillation and thromboembolic events, especially stroke …

Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the …

G Ntaios, H Baumgartner, W Doehner… - European Heart …, 2024 - academic.oup.com
One in six ischaemic stroke patients has an embolic stroke of undetermined source (ESUS),
defined as a stroke with unclear aetiology despite recommended diagnostic evaluation. The …

[HTML][HTML] Thromboembolic risk and oral anticoagulation in subclinical atrial fibrillation

FK Wegner, L Eckardt - Trends in Cardiovascular Medicine, 2024 - Elsevier
Availability of devices capable of continuous rhythm monitoring such as smartwatches,
implantable loop recorders, or pacemakers/defibrillators is continuously increasing …